Search
Contineum Therapeutics Inc
CTNMAdd to Watchlist
15.490USD
-0.260-1.65%
Close 07-31 16:00（ET）Quotes delayed by 15 min
582.75MMarket Cap
LossP/E TTM
CTNM Financials
See Contineum Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Contineum Therapeutics Inc Earnings Date
Latest Release
Jul 30, 2026
EPS / Forecast
-0.40/-0.45
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.17
0.84%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its current assets were 267.92M, with a year-on-year change of 29.81.
What are the total assets of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its total assets of Contineum Therapeutics Inc were 276.64M, with a year-on-year change of 29.97.
What are the total liabilities of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its total liabilities of Contineum Therapeutics Inc were 15.65M, with a year-on-year change of 5.90.
What is the total equity of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its total equity of Contineum Therapeutics Inc was 260.99M, with a year-on-year change of 31.77.
What is the net operating income of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its net operating income of Contineum Therapeutics Inc was -68.06M, with a year-on-year change of -33.73.
What is the net investment of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its net investment of Contineum Therapeutics Inc was -3.71M, with a year-on-year change of 94.68.
What is the net financing of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its net financing of Contineum Therapeutics Inc was 112.69M, with a year-on-year change of 3.38.
What is the Earnings Per Share (EPS) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.17, with a year-on-year change of 0.84.
What is the net income of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its net income was -59.98M, with a year-on-year change of -41.93.
What is the Return on Equity (ROE) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -26.13, with a year-on-year change of 59.77.
What is the Return on Assets (ROA) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -24.51, with a year-on-year change of 0.48.
What is the operating profit of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its operating profit was -68.06M, with a year-on-year change of -33.73.